Eli Lilly & Co. (LLY)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Eli Lilly & Co. (LLY)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Key Insights
Critical company metrics and information
Share Price
$826.71Market Cap
$743.47 BillionTotal Outstanding Shares
949.32 Million SharesTotal Employees
43,000Dividend
$1.3 Per Share QuarterlyIPO Date
July 9, 1970SIC Description
Pharmaceutical PreparationsHomepage
https://www.lilly.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $5.00 Billion |
Net Cash Flow From Financing Activities | $5.00 Billion |
Exchange Gains/Losses | $261.10 Million |
Net Cash Flow | $988.20 Million |
Net Cash Flow From Operating Activities | $6.03 Billion |
Net Cash Flow From Investing Activities | $-10.31 Billion |
Net Cash Flow, Continuing | $727.10 Million |
Net Cash Flow From Investing Activities, Continuing | $-10.31 Billion |
Net Cash Flow From Operating Activities, Continuing | $6.03 Billion |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Operating Expenses | $14.82 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Diluted Average Shares | $904.58 Million |
Costs And Expenses | $30.71 Billion |
Gross Profit | $33.06 Billion |
Basic Earnings Per Share | $9.29 |
Operating Income/Loss | $10.15 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $8.37 Billion |
Cost Of Revenue | $7.80 Billion |
Operating Expenses | $22.91 Billion |
Nonoperating Income/Loss | $12.50 Million |
Income/Loss From Continuing Operations Before Tax | $10.15 Billion |
Net Income/Loss | $8.37 Billion |
Selling, General, and Administrative Expenses | $8.09 Billion |
Benefits Costs and Expenses | $30.71 Billion |
Diluted Earnings Per Share | $9.25 |
Net Income/Loss Attributable To Parent | $8.37 Billion |
Income/Loss From Continuing Operations After Tax | $8.37 Billion |
Revenues | $40.86 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income Tax Expense/Benefit | $1.78 Billion |
Basic Average Shares | $900.88 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Liabilities | $61.29 Billion |
Wages | $1.70 Billion |
Noncurrent Assets | $44.19 Billion |
Intangible Assets | $6.54 Billion |
Other Current Liabilities | $20.08 Billion |
Other Current Assets | $15.70 Billion |
Accounts Payable | $2.89 Billion |
Noncurrent Liabilities | $36.61 Billion |
Prepaid Expenses | $8.25 Billion |
Current Liabilities | $24.67 Billion |
Equity | $14.32 Billion |
Assets | $75.61 Billion |
Current Assets | $31.42 Billion |
Fixed Assets | $16.17 Billion |
Inventory | $7.46 Billion |
Other Non-current Assets | $21.48 Billion |
Equity Attributable To Noncontrolling Interest | $80.70 Million |
Equity Attributable To Parent | $14.24 Billion |
Liabilities And Equity | $75.61 Billion |
Historical Dividends
Current dividend: $1.3 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Oct 28, 2024 | Dec 10, 2024 | Nov 15, 2024 | $1.3 | Quarterly |
Jun 24, 2024 | Sep 10, 2024 | Aug 15, 2024 | $1.3 | Quarterly |
May 6, 2024 | Jun 10, 2024 | May 16, 2024 | $1.3 | Quarterly |
Dec 8, 2023 | Mar 8, 2024 | Feb 15, 2024 | $1.3 | Quarterly |
Nov 1, 2023 | Dec 8, 2023 | Nov 15, 2023 | $1.13 | Quarterly |
Jun 26, 2023 | Sep 8, 2023 | Aug 15, 2023 | $1.13 | Quarterly |
May 1, 2023 | Jun 9, 2023 | May 15, 2023 | $1.13 | Quarterly |
Dec 12, 2022 | Mar 10, 2023 | Feb 15, 2023 | $1.13 | Quarterly |
Oct 17, 2022 | Dec 9, 2022 | Nov 15, 2022 | $0.98 | Quarterly |
Jun 27, 2022 | Sep 9, 2022 | Aug 15, 2022 | $0.98 | Quarterly |
May 2, 2022 | Jun 10, 2022 | May 16, 2022 | $0.98 | Quarterly |
Dec 13, 2021 | Mar 10, 2022 | Feb 15, 2022 | $0.98 | Quarterly |
Oct 18, 2021 | Dec 10, 2021 | Nov 15, 2021 | $0.85 | Quarterly |
Jun 29, 2021 | Sep 10, 2021 | Aug 13, 2021 | $0.85 | Quarterly |
May 3, 2021 | Jun 10, 2021 | May 14, 2021 | $0.85 | Quarterly |
Dec 14, 2020 | Mar 10, 2021 | Feb 12, 2021 | $0.85 | Quarterly |
Oct 19, 2020 | Dec 10, 2020 | Nov 13, 2020 | $0.74 | Quarterly |
Jul 15, 2020 | Sep 10, 2020 | Aug 14, 2020 | $0.74 | Quarterly |
May 4, 2020 | Jun 10, 2020 | May 15, 2020 | $0.74 | Quarterly |
Dec 16, 2019 | Mar 10, 2020 | Feb 14, 2020 | $0.74 | Quarterly |
Oct 21, 2019 | Dec 10, 2019 | Nov 15, 2019 | $0.645 | Quarterly |
Jun 19, 2019 | Sep 10, 2019 | Aug 15, 2019 | $0.645 | Quarterly |
May 6, 2019 | Jun 10, 2019 | May 17, 2019 | $0.645 | Quarterly |
Dec 19, 2018 | Mar 8, 2019 | Feb 15, 2019 | $0.645 | Quarterly |
Oct 15, 2018 | Dec 10, 2018 | Nov 15, 2018 | $0.5625 | Quarterly |
Jun 18, 2018 | Sep 10, 2018 | Aug 15, 2018 | $0.5625 | Quarterly |
May 7, 2018 | Jun 8, 2018 | May 17, 2018 | $0.5625 | Quarterly |
Dec 11, 2017 | Mar 9, 2018 | Feb 15, 2018 | $0.5625 | Quarterly |
Oct 16, 2017 | Dec 8, 2017 | Nov 15, 2017 | $0.52 | Quarterly |
Jun 19, 2017 | Sep 8, 2017 | Aug 15, 2017 | $0.52 | Quarterly |
May 1, 2017 | Jun 9, 2017 | May 15, 2017 | $0.52 | Quarterly |
Dec 12, 2016 | Mar 10, 2017 | Feb 15, 2017 | $0.52 | Quarterly |
Oct 17, 2016 | Dec 9, 2016 | Nov 15, 2016 | $0.51 | Quarterly |
Jun 20, 2016 | Sep 9, 2016 | Aug 15, 2016 | $0.51 | Quarterly |
May 2, 2016 | Jun 10, 2016 | May 13, 2016 | $0.51 | Quarterly |
Dec 8, 2015 | Mar 10, 2016 | Feb 12, 2016 | $0.51 | Quarterly |
Oct 19, 2015 | Dec 10, 2015 | Nov 13, 2015 | $0.5 | Quarterly |
May 4, 2015 | Jun 10, 2015 | May 18, 2015 | $0.5 | Quarterly |
Dec 15, 2014 | Mar 10, 2015 | Feb 13, 2015 | $0.5 | Quarterly |
Oct 20, 2014 | Dec 10, 2014 | Nov 14, 2014 | $0.49 | Quarterly |
Jun 16, 2014 | Sep 10, 2014 | Aug 15, 2014 | $0.49 | Quarterly |
May 5, 2014 | Jun 10, 2014 | May 15, 2014 | $0.49 | Quarterly |
Dec 16, 2013 | Mar 10, 2014 | Feb 14, 2014 | $0.49 | Quarterly |
Oct 21, 2013 | Dec 10, 2013 | Nov 15, 2013 | $0.49 | Quarterly |
Jun 18, 2013 | Sep 10, 2013 | Aug 15, 2013 | $0.49 | Quarterly |
May 6, 2013 | Jun 10, 2013 | May 16, 2013 | $0.49 | Quarterly |
Dec 17, 2012 | Mar 8, 2013 | Feb 15, 2013 | $0.49 | Quarterly |
Oct 15, 2012 | Dec 10, 2012 | Nov 15, 2012 | $0.49 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Eli Lilly & Co. (LLY)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.